LTZ Therapeutics Employee Directory

LTZ Therapeutics corporate office is located in 1100 Island Dr Ste 103, Redwood City, California, 94065, United States and has 11-50 employees.

Employees by Department

Departments

Number of employees

Engineering & Technical

7

C-Suite

2

Finance

2

Legal

1

Medical & Health

1

LTZ Therapeutics CEO

Robert Li, Founder & Chief Executive Officer at LTZ Therapeutics
United States flag for contact location.
Robert LiFounder & Chief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of LTZ Therapeutics

  • PL
    United States flag for contact location.
    Phillip Lee

    Chief Financial Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

LTZ Therapeutics Global Presence

globalPresence illustration
North America11-50
Asia1-10
Europe1-10

Index of contact profiles from LTZ Therapeutics

Hundreds of professionals searching for LTZ Therapeutics have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

People from Similar Companies in the Business Services Industry Located in California, United States

Frequently Asked Questions Regarding LTZ Therapeutics Employees

How many employees does LTZ Therapeutics have?
LTZ Therapeutics has 11-50 employees
Who is the CEO of LTZ Therapeutics?
LTZ Therapeutics’s CEO is Robert Li
Who is the CFO of LTZ Therapeutics?
LTZ Therapeutics’s CFO is Phillip Lee
Who are LTZ Therapeutics key employees?
Some of LTZ Therapeutics key employees are Phillip Lee
Where is LTZ Therapeutics located?
LTZ Therapeutics’s headquarters are located at 1100 Island Dr Ste 103, Redwood City, California, 94065, United States
How do I contact LTZ Therapeutics?
LTZ Therapeutics Contact Info: Website: www.ltztherapeutics.com
What does LTZ Therapeutics do?

LTZs approach focuses on the fusion of reverse translational science, with a deep understanding of tumor microenvironment (TME) biology especially myeloid biology. Macrophages appear to be one of the most prevalent immune cell populations in TME of various hematologic and solid tumors. Therefore, effectively engaging and activating macrophages to k... ill cancer cells offers significant therapeutic potential for patients. LTZ is developing its own U-MCE Platform to primarily enhance the phagocytic function of monocytes and macrophages of different polarization states to foster anti-tumor immunity and offer potential therapeutic benefit for other non-oncology diseases.Read More

Is LTZ Therapeutics a public company?
LTZ Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about LTZ Therapeutics Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.